JPWO2022013321A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022013321A5
JPWO2022013321A5 JP2023502699A JP2023502699A JPWO2022013321A5 JP WO2022013321 A5 JPWO2022013321 A5 JP WO2022013321A5 JP 2023502699 A JP2023502699 A JP 2023502699A JP 2023502699 A JP2023502699 A JP 2023502699A JP WO2022013321 A5 JPWO2022013321 A5 JP WO2022013321A5
Authority
JP
Japan
Prior art keywords
ssx1
hud
tumor marker
koc
sox2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023502699A
Other languages
English (en)
Japanese (ja)
Other versions
JP7744641B2 (ja
JP2023533815A (ja
Publication date
Priority claimed from CN202010677754.6A external-priority patent/CN113933509A/zh
Priority claimed from GB2017434.8A external-priority patent/GB2600701A/en
Application filed filed Critical
Priority claimed from PCT/EP2021/069668 external-priority patent/WO2022013321A2/en
Publication of JP2023533815A publication Critical patent/JP2023533815A/ja
Publication of JPWO2022013321A5 publication Critical patent/JPWO2022013321A5/ja
Application granted granted Critical
Publication of JP7744641B2 publication Critical patent/JP7744641B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023502699A 2020-07-14 2021-07-14 肺癌における自己抗体を検出するための抗原の組合せの使用 Active JP7744641B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202010677754.6A CN113933509A (zh) 2020-07-14 2020-07-14 抗体测定
CN202010677754.6 2020-07-14
GB2017434.8 2020-11-04
GB2017434.8A GB2600701A (en) 2020-11-04 2020-11-04 Antibody assay
PCT/EP2021/069668 WO2022013321A2 (en) 2020-07-14 2021-07-14 Antibody assay

Publications (3)

Publication Number Publication Date
JP2023533815A JP2023533815A (ja) 2023-08-04
JPWO2022013321A5 true JPWO2022013321A5 (enExample) 2024-07-25
JP7744641B2 JP7744641B2 (ja) 2025-09-26

Family

ID=76971915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502699A Active JP7744641B2 (ja) 2020-07-14 2021-07-14 肺癌における自己抗体を検出するための抗原の組合せの使用

Country Status (6)

Country Link
US (1) US20230266331A1 (enExample)
EP (1) EP4182693A2 (enExample)
JP (1) JP7744641B2 (enExample)
KR (1) KR20230068378A (enExample)
CN (1) CN116324412A (enExample)
WO (1) WO2022013321A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024197052A1 (en) * 2023-03-20 2024-09-26 Rush University Medical Center Circulating autoantibody biomarkers to supplement lung cancer screening

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB2424070B (en) 2002-11-14 2007-06-27 Univ Nottingham Methods for preparing tumour marker proteins
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
US20100204055A1 (en) * 2008-12-05 2010-08-12 Bonner-Ferraby Phoebe W Autoantibody detection systems and methods
CN103383395B (zh) * 2013-07-10 2015-09-09 杭州市第一人民医院 一种用于检测肺癌自身抗体的液相芯片试剂盒
CN103869086B (zh) * 2014-04-14 2016-02-17 杭州凯保罗生物科技有限公司 一种血清自身抗体检测试剂盒
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN110716050A (zh) * 2019-11-13 2020-01-21 基因科技（上海）股份有限公司 抗原组合在制备用于肺癌相关自身抗体检测的试剂盒中的用途以及相应的试剂盒和检测方法

Similar Documents

Publication Publication Date Title
US8592169B2 (en) Tumour marker proteins and uses thereof
US20090047689A1 (en) Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
WO2022083673A1 (zh) 食管癌的生物标志物及其应用
CN108107218B (zh) 抗体测定
CA2755486A1 (en) Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer
EP3631456A1 (en) Method of detecting colitis ulcerosa
CN115877006A (zh) 卵巢癌相关的生物标志物及其应用
EP3167286A1 (en) Autoantibody profiling in aps
JPWO2022013321A5 (enExample)
CN103257227B (zh) 改进的免疫测定方法
US20100248269A1 (en) Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer
JP7744641B2 (ja) 肺癌における自己抗体を検出するための抗原の組合せの使用
CN109313193B (zh) 消化道癌的判定方法
CN113702636B (zh) 血浆自身抗体标志物在乳腺癌早期诊断及其分子亚型表征中的应用
EP4004549A1 (en) Progression markers for colorectal adenomas
KR102621473B1 (ko) 성인형 스틸병 진단용 바이오마커 조성물
Arjomandi et al. A novel algorithm to improve specificity in ovarian cancer detection
US20240319194A1 (en) Diagnosis and treatment of pancreatic cancer
EP2376921A1 (en) Detection of ifi16 in body fluids
CN113933509A (zh) 抗体测定
GB2600701A (en) Antibody assay
EP0724158A1 (en) Method of immunoassaying autoantibody
WO2023201426A1 (en) Novel diagnostic method for detection of myasthenia gravis
KR20130086898A (ko) 유방암 환자의 화학요법제 저항성 예측을 위한 혈청 바이오마커
TW201928351A (zh) 抗體測定